A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

Lecanemab, as the drug is known, was approved by Health Canada this week. It is the first treatment available in Canada to ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

TORONTO – Health Canada has authorized a drug shown to slow the progression of Alzheimer’s disease.   Lecanemab is the first ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

The NDA submission is supported by data from two pivotal Phase 3 clinical trials, which evaluated MK-6240’s performance in detecting tau pathology in early Alzheimer’s disease. These studies met their ...

Neurologists at Florida Atlantic University have launched a new research tool combining focused ultrasound and magnetic ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...